Latest News
Lipocine Inc.
- Lipocine Inc. Estimates – NASDAQ:LPCN
- Lipocine Updates Investor Presentation to Reflect Strategy
- Form 8K Lipocine Inc For: 20 October By Investing.com
- Why Is Lipocine Stock Soaring Today? - Lipocine (NASDAQ:LPCN)
- Lipocine Shares Surge 30% After Health Canada Clears Oral Testosterone Drug
- Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
- LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today
- Lipocine (LPCN) Advances BLOOM Trial As Traders Eye Cash Runway
- Hecla Mining, XPO, Lipocine
- Lipocine (LPCN) Jumps As BLOOM Phase 3 Trial Kicks Off
- Health Canada approves Lipocine’s testosterone therapy drug
- Lipocine director John Higuchi buys $27,131 in company stock By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →